Coverage policy determination initiated with 5 Medicare MACs for HeartFlow’s AI-QCT revolutionizing cardiovascular care for patients
News | FFR Technologies
HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage

June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy ...

Home June 04, 2024
Home
The non-surgical device prevents dangerous plaque buildup in neck arteries from cutting off oxygen to the brain
News | Stents
HonorHealth Research Institute First in Southwest to Implant New Stroke Prevention Stent

June 4, 2024 — A patient at HonorHealth Research Institute is one of the nation’s first — and the first in Arizona and ...

Home June 04, 2024
Home
By embracing these cutting-edge health solutions, we have an opportunity to revolutionize stroke recovery and ensure all patients have the resources they need for a healthier future.
Feature | Stroke | By Pamela W. Duncan, PhD
Bridging the Gap: Enhancing Stroke Recovery Through Digital Health Solutions

Stroke recovery is a challenging process that extends for months after hospital discharge. Issues like cognitive ...

Home June 04, 2024
Home
The 35th Annual ASE Scientific Sessions, will be held June 14-16, at the Oregon Convention Center in Portland, OR, with an expansive program focused on “Global Echocardiography: Innovations in Diagnosis and Beyond.”
Feature | ASE | Christine Book
American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights

June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific ...

Home June 04, 2024
Home
Here is a look at what DAIC viewers were reading on dicardiology.com in May
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: Must-reads from the Month of May

Here is a look at the Top 10 pieces of content viewers were reading during the month of May. 1. American College of ...

Home June 04, 2024
Home
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events.
News | Artificial Intelligence
Landmark Clinical Study in The Lancet Finds New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation at Least 10 Years in Advance

June 4, 2024 — Caristo Diagnostics Limited, a global provider of cardiovascular disease diagnostics and risk prediction ...

Home June 04, 2024
Home
Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program recently reported it has reached a significant milestone of performing over 5,000 transcatheter aortic valve replacement (TAVR) procedures, the first in New Jersey and among the first to accomplish this in the United States.
News | Cardiovascular Surgery
Atlantic Health System’s Morristown Medical Center Tops 5,000 TAVR Procedures

June 3, 2024 — Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program recently reported ...

Home June 03, 2024
Home
Heuron ICH has received FDA 510(k) clearance
News | FDA
Heuron Gets FDA Green Light for Stroke Triage and Notification Solution

June 3, 2024 — Heuron, a specialized medical AI startup focused on brain and neurological disorders based in South Korea ...

Home June 03, 2024
Home
DESyne BDS Plus system with site-specific antithrombotic therapeutic (TRx) significantly reduced the risk of TLF versus conventional drug-eluting stent through 12-months
News | Cardiovascular Clinical Studies
Elixir Medical’s Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World’s First Site-Specific Antithrombotic Therapeutic Compared to DES

June 3, 2024 — Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease ...

Home June 03, 2024
Home
HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation
News
HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

June 3, 2024 — HighLife SAS, a medtech company focused on the development of a novel Trans-Septal Mitral Valve ...

Home June 03, 2024
Home
Acquisition creates greater opportunity to transform the treatment landscape for cardiovascular disease
News | Cardiovascular Business
Johnson and Johnson Completes Acquisition of Shockwave Medical

May 31, 2024 — Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part ...

Home May 31, 2024
Home
Conference focuses on rapidly expanding field of sports cardiology and increasing demand for CV care teams who care for athletes
News | Cardiovascular Education
American College of Cardiology Announces Care of the Athletic Heart

May 31, 2024 — In the United States there are over 8 million active athletes. Given the rapid expansion of sports ...

Home May 31, 2024
Home
Cardiologists performed the fewest biopsies after dual negative HeartCare results compared to single or dual positive results
News | Cardiovascular Clinical Studies
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies

May 31, 2024 — CareDx, a leading precision medicine company focused on the discovery, development, and commercialization ...

Home May 31, 2024
Home
This collaboration integrates HBox.ai's virtual care model with InfoBionic.AI's advanced cardiac telemetry, offering AI-driven tools for virtual consults, remote monitoring, and diagnostic care
News | Artificial Intelligence
InfoBionic.Ai and HBox.ai Ink Partnership to Offer the First AI-Driven "Cardiology Clinic of the Future"

May 31, 2024 — InfoBionic.ai and HBox.ai announced a groundbreaking partnership that brings together the leading AI ...

Home May 31, 2024
Home
Elixir Medical recently announced that the PINNACLE I study, evaluating the safety and performance of its LithiX Hertz Contact Intravascular Lithotripsy System (IVL) met its primary safety and effectiveness endpoint of clinical success. Shown here: Elixir Medical CEO Motasim Sirhan.
News | EuroPCR
Elixir Medical PINNACLE I Study of LithiX IVL System Meets Primary Endpoints of Clinical Success

May 30, 2024 — Elixir Medical, a developer of technologies to treat cardiovascular and peripheral disease, announced ...

Home May 30, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now